![Santhera and ReveraGen Announce FDA Acceptance of New Drug Application for Vamorolone in Duchenne Muscular Dystrophy - Jett Foundation Santhera and ReveraGen Announce FDA Acceptance of New Drug Application for Vamorolone in Duchenne Muscular Dystrophy - Jett Foundation](https://www.jettfoundation.org/wp-content/uploads/2022/06/Santhera-industrynewsgraphic-01-1024x446.png)
Santhera and ReveraGen Announce FDA Acceptance of New Drug Application for Vamorolone in Duchenne Muscular Dystrophy - Jett Foundation
![Vamorolone trial in Duchenne muscular dystrophy shows dose-related improvement of muscle function | Neurology Vamorolone trial in Duchenne muscular dystrophy shows dose-related improvement of muscle function | Neurology](https://n.neurology.org/content/neurology/93/13/e1312/T3/graphic-8.medium.gif)
Vamorolone trial in Duchenne muscular dystrophy shows dose-related improvement of muscle function | Neurology
![VISION-DMD – Designed to ensure a timely & cost-effective drug development for Duchenne muscular dystrophy VISION-DMD – Designed to ensure a timely & cost-effective drug development for Duchenne muscular dystrophy](https://vision-dmd.info/vision1/wp-content/uploads/2018/03/brochure-front-e1532944214613.jpg)
VISION-DMD – Designed to ensure a timely & cost-effective drug development for Duchenne muscular dystrophy
![WATCH: Vamorolone Clinical Trials in Duchenne - Webinar Recording - Parent Project Muscular Dystrophy WATCH: Vamorolone Clinical Trials in Duchenne - Webinar Recording - Parent Project Muscular Dystrophy](https://www.parentprojectmd.org/wp-content/uploads/2019/02/webinar_reveragen-1.png)
WATCH: Vamorolone Clinical Trials in Duchenne - Webinar Recording - Parent Project Muscular Dystrophy
![1st Patient Dosed in Pilot Trial of Vamorolone for Becker MD | Medication May Work With Fewer Side Effects Than Corticosteroids | Muscular Dystrophy News Today 1st Patient Dosed in Pilot Trial of Vamorolone for Becker MD | Medication May Work With Fewer Side Effects Than Corticosteroids | Muscular Dystrophy News Today](https://musculardystrophynews.com/wp-content/uploads/2022/08/Clinicalgraphs.png)
1st Patient Dosed in Pilot Trial of Vamorolone for Becker MD | Medication May Work With Fewer Side Effects Than Corticosteroids | Muscular Dystrophy News Today
![Vamorolone treatment following disease induction reduces the severity... | Download Scientific Diagram Vamorolone treatment following disease induction reduces the severity... | Download Scientific Diagram](https://www.researchgate.net/publication/335387404/figure/fig1/AS:959995134885914@1605892084525/Vamorolone-treatment-following-disease-induction-reduces-the-severity-of-collagen.png)
Vamorolone treatment following disease induction reduces the severity... | Download Scientific Diagram
![Clinical Trial Alert: Phase 2 Study of Vamorolone in Adults with BMD - Quest | Muscular Dystrophy Association Clinical Trial Alert: Phase 2 Study of Vamorolone in Adults with BMD - Quest | Muscular Dystrophy Association](https://mdaquest.org/wp-content/uploads/2022/11/1OkqFGdQ-1024x512.jpeg)
Clinical Trial Alert: Phase 2 Study of Vamorolone in Adults with BMD - Quest | Muscular Dystrophy Association
![Membrane Stabilization by Modified Steroid Offers a Potential Therapy for Muscular Dystrophy Due to Dysferlin Deficit: Molecular Therapy Membrane Stabilization by Modified Steroid Offers a Potential Therapy for Muscular Dystrophy Due to Dysferlin Deficit: Molecular Therapy](https://www.cell.com/cms/attachment/371ae0ed-eb6f-4512-87a0-09c8ce3545da/fx1.jpg)
Membrane Stabilization by Modified Steroid Offers a Potential Therapy for Muscular Dystrophy Due to Dysferlin Deficit: Molecular Therapy
![Phase IIa trial in Duchenne muscular dystrophy shows vamorolone is a first-in-class dissociative steroidal anti-inflammatory drug - ScienceDirect Phase IIa trial in Duchenne muscular dystrophy shows vamorolone is a first-in-class dissociative steroidal anti-inflammatory drug - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1043661818309757-ga1.jpg)
Phase IIa trial in Duchenne muscular dystrophy shows vamorolone is a first-in-class dissociative steroidal anti-inflammatory drug - ScienceDirect
![ReveraGen BioPharma's DMD Drug Vamorolone Gets FDA Fast Track Designation - Muscular Dystrophy Association ReveraGen BioPharma's DMD Drug Vamorolone Gets FDA Fast Track Designation - Muscular Dystrophy Association](https://s3.amazonaws.com/mda-strongly/wp-content/uploads/2017/03/27130859/MicroscopeCloseup.jpg)
ReveraGen BioPharma's DMD Drug Vamorolone Gets FDA Fast Track Designation - Muscular Dystrophy Association
![Santhera Shares Community Update on Phase 2b Trial for Vamorolone - Parent Project Muscular Dystrophy Santhera Shares Community Update on Phase 2b Trial for Vamorolone - Parent Project Muscular Dystrophy](https://www.parentprojectmd.org/wp-content/uploads/2021/02/blog_santhera-2021.png)